{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:41:09Z","timestamp":1792604469076,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.semnephrol.2023.151483","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T23:18:00Z","timestamp":1705187880000},"page":"151483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help"],"prefix":"10.1016","volume":"43","author":[{"given":"Florine V.","family":"Janssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2023.151483_bib0001","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2215\/CJN.07640810","article-title":"Belding Hibbard Scribner\u2014better known as Scrib","volume":"5","author":"Blagg","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0272-6386(87)80092-6","article-title":"Reducing the hemorrhagic complications of hemodialysis: A controlled comparison of low-dose heparin and citrate anticoagulation","volume":"9","author":"Flanigan","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0003","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/ndt\/gfq225","article-title":"Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding","volume":"25","author":"Kreuzer","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0004","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/hdi.12563","article-title":"Efficacy and safety of low-dose heparin in hemodialysis","volume":"22","author":"Murea","year":"2018","journal-title":"Hemodial Int"},{"issue":"suppl 7","key":"10.1016\/j.semnephrol.2023.151483_bib0005","first-page":"63","article-title":"Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0006","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12882-019-1527-3","article-title":"Renal Association Clinical Practice Guideline on haemodialysis","volume":"20","author":"Ashby","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0007","unstructured":"BC van Jaarsveld. Antistolling bij hemodialyse. Nederlandse Federatie Voor Nefrologie. 2012. Accessed 19 october 2023. https:\/\/www.nefro.nl\/richtlijnen\/antistolling-bij-hemodialyse-2012."},{"key":"10.1016\/j.semnephrol.2023.151483_bib0008","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","article-title":"KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151483_bib0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/1744-9987.12294","article-title":"Japanese Society for Dialysis Therapy clinical guideline for \u201cMaintenance hemodialysis: Hemodialysis prescriptions.\u201d","volume":"19","author":"Watanabe","year":"2015","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0010","doi-asserted-by":"crossref","unstructured":"Weinreich T, B\u00f6hler J, Kuhlmann M et al. Dialysestandard der Deutschen Gesellschaft f\u00fcr Nephrologie. Deutsche Gesellschaft f\u00fcr Nephrologie; 2016. Accessed 19 October 2023. https:\/\/www.dgfn.eu\/dialyse-standard.html.","DOI":"10.1055\/s-0034-1544102"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0011","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0272-6386(00)70203-4","article-title":"Dialysate made from dry chemicals using citric acid increases dialysis dose","volume":"35","author":"Ahmad","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0012","doi-asserted-by":"crossref","first-page":"734","DOI":"10.5301\/ijao.5000358","article-title":"Heparin and albumin as part of the priming solution limits exposure to anticoagulation during hemodialysis: In vitro studies","volume":"37","author":"Kyrk","year":"2014","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0013","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5301\/ijao.5000253","article-title":"Rinsing the extra corporeal circuit with a heparin and albumin solution reduces the need for systemic anticoagulant in hemodialysis","volume":"36","author":"Fransson","year":"2013","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hdi.12472","article-title":"Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding","volume":"21","author":"Skagerlind","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00228-017-2389-x","article-title":"An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis","volume":"74","author":"Skagerlind","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0016","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ekir.2019.07.010","article-title":"Evaluation of different dialyzers and the impact of predialysis albumin priming in intermittent hemodialysis with reduced anticoagulation","volume":"4","author":"Vanommeslaeghe","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.mat.0000169119.06419.ed","article-title":"Assessment of heparin binding to the AN69 ST hemodialysis membrane: I. Preclinical studies","volume":"51","author":"Chanard","year":"2005","journal-title":"ASAIO J"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.ajkd.2021.04.004","article-title":"Dialyzer performance during hemodialysis without systemic anticoagulation using a heparin-grafted dialyzer combined with a citrate-enriched dialysate: Results of the randomized crossover noninferiority EvoCit study","volume":"79","author":"Fran\u00e7ois","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0019","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.mat.0000169121.09075.53","article-title":"Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration","volume":"51","author":"Lavaud","year":"2005","journal-title":"ASAIO J"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0020","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/hdi.12507","article-title":"Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report","volume":"21","author":"Lim","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0021","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ckj\/sfaa228","article-title":"Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: The SAFE study","volume":"14","author":"Vandenbosch","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0022","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/hdi.12774","article-title":"Hemodialysis without anticoagulation: Less clotting in conventional hemodialysis than in predilution hemodiafiltration","volume":"23","author":"Krummel","year":"2019","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0023","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ki.2014.225","article-title":"Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis","volume":"86","author":"Laville","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1525-1594.2010.01038.x","article-title":"Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect","volume":"35","author":"Richtrova","year":"2011","journal-title":"Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0025","doi-asserted-by":"crossref","first-page":"e97187","DOI":"10.1371\/journal.pone.0097187","article-title":"Hemodialysis without systemic anticoagulation: A prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding","volume":"9","author":"Gu\u00e9ry","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0026","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ndt\/gfq396","article-title":"Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study","volume":"26","author":"Cheng","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0027","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jvs.2014.12.050","article-title":"Role of high shear rate in thrombosis","volume":"61","author":"Casa","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0028","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2215\/CJN.02590409","article-title":"Increased efficiency of hemodialysis with citrate dialysate: A prospective controlled study","volume":"4","author":"Kossmann","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0029","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/ndt\/gfv248","article-title":"Improved survival associated with acetate-free haemodialysis in elderly: A registry-based study","volume":"30","author":"Mercadal","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0030","unstructured":"Utilisation du dialysat au citrate : R\u00e9union des parties prenantes \u00e0 l\u2019ANSM sur une \u00e9ventuelle surmortalit\u00e9 li\u00e9e \u00e0 l\u2019utilisation du dialysat au citrate - Communiqu\u00e9. Agence nationale de s\u00e9curit\u00e9 du medicament et des produits de sant\u00e9; 2018. Accessed 19 October 2023.https:\/\/ansm.sante.fr\/actualites\/utilisation-du-dialysat-au-citrate-reunion-des-parties-prenantes-a-lansm-sur-une-eventuelle-surmortalite-liee-a-lutilisation-du-dialysat-au-citrate-communique."},{"key":"10.1016\/j.semnephrol.2023.151483_bib0031","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfaa089","article-title":"Long-term mortality risk associated with citric acid- and acetic acid-based bicarbonate haemodialysis: A historical cohort propensity score-matched study in a large, multicentre, population-based study","volume":"35","author":"Neri","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0032","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/gfz274","article-title":"Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: A survival propensity score-matched study in western France","volume":"35","author":"Potier","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0033","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1159\/000502939","article-title":"Impact of long-term citrate dialysate use on survival in haemodialysis patients","volume":"49","author":"Seret","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0034","doi-asserted-by":"crossref","first-page":"666","DOI":"10.34067\/KID.0006182020","article-title":"Citric acid-containing dialysate and survival rate in the Dialysis Outcomes and Practice Patterns Study","volume":"2","author":"Urena-Torres","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0035","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/gfaa168","article-title":"Impact of the dialysate acid component on haemodialysis mortality rates","volume":"35","author":"Couchoud","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0036","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2369-15-104","article-title":"Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: A retrospective cohort study","volume":"15","author":"Francois","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0037","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ndt\/gfw461","article-title":"A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: Results of the CiTED study","volume":"32","author":"Meijers","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151483_bib0038","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.ajkd.2007.02.001","article-title":"Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: A prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding","volume":"49","author":"Evenepoel","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151483_bib0039","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.05.013","article-title":"Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: A multicenter, randomized, crossover trial","volume":"68","author":"Islam","year":"2016","journal-title":"Am J Kidney Dis"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:50:46Z","timestamp":1748357446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0270929523001936"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151483","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151483"}}